CATX
CATX
AMEX · Biotechnology

Perspective Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.85
-0.05 (-1.28%)
As of May 9, 1:46 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +410.9% upside
Low Target $12.33
Average Target $19.67
High Target $23.14
Current Price $3.85
Current
$3.85
Target
$19.67
$12.33 $19.67 avg $23.14
Scenario Analysis
Bear Case
$12.33
220.3%
Low target
Base Case
$19.67
+410.9%
Avg target
Bull Case
$23.14
+501.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$6.16
-37.5% from high
52-Week Low
$1.96
+96.9% from low
Target vs 52W High
$19.67
+219.3% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.30
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%